echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New discovery: A small molecule can cause amyloid tangles in Alzheimer's disease

    New discovery: A small molecule can cause amyloid tangles in Alzheimer's disease

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Using a molecule found in green tea, UCLA scientists have discovered other molecules that break down protein tangles in the brain that are thought to cause Alzheimer's disease and similar diseases
    .


    The green tea molecule EGCG is known to destroy tau fibers, which tangle and attack neurons, causing neurons to die
    .


    In a paper published in Nature Communications, UCLA biochemists describe how EGCG breaks tau fibers layer by
    layer.


    Thousands of J-shaped tau molecular layers bind together to form an amyloid fibrils
    called "tangles.


    David Eisenberg, a professor of chemistry and biochemistry at UCLA, said: "If we can break down these fibers, we may be able to stop the death
    of neurons.


    EGCG has been extensively studied, but has never been used as a drug to treat Alzheimer's disease because it works best in breaking down tau fibers in water and does not easily enter cells or brains
    .


    To study the mechanism by which EGCG breaks down tau protein fibers, the researchers extracted tau protein tangles from the brains of people who died of Alzheimer's and incubated them with EGCG at different times
    .


    Images of EGCG-induced mid-degradation fibrils were snap-frozen, and images of these frozen samples showed how EGCG broke fibrils into distinctly harmless fragments
    .


    "The EGCG molecule binds to each layer of fiber, but the molecule wants to be closer
    .


    Kevin Murray, then a PhD student at UCLA and now working in the Department of Neurology at Brown University, discovered specific locations
    called pharmacophores on tau fibers to which EGCG molecules are attached.


    "Using UCLA's supercomputing resources, we can sift
    through a large library of drugs before any wet lab experiments are needed," Murray said.


    "For cancer and many metabolic diseases, understanding the structure of disease-causing proteins has led to effective drugs
    that block the causative effects," Eisenberg said.


    CNS-11 is not yet a drug, but the authors call it a pilot
    .



    Paul M.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.